Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|March 26, 2013
National Institutes of Health funding in radiation oncology: a snapshotMichael Steinberg, William H McBride, Erina Vlashi, et al.
Free Radical Biology & Medicine|April 18, 2002
N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activationFrank Pajonk, Katrin Riess, Alfred Sommer, et al.
Oncogene|October 14, 2004
The erythropoietin-receptor pathway modulates survival of cancer cellsFrank Pajonk, Antonia Weil, Alfred Sommer, et al.
BMC Cancer|July 9, 2005
The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanismFrank Pajonk, Arndt van Ophoven, Christian Weissenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2025
The Mevalonate Pathway in the Radiation Response of CancerLinda Azizi, Hannah Hausman, Alexandra K Meyer, et al.
Military Medicine|March 5, 2002
NF-kappa B, cytokines, proteasomes, and low-dose radiation exposureWilliam H McBride, Frank Pajonk, Chi-Shuin Chiang, et al.
BMC Medicine|December 5, 2006
The effects of tea extracts on proinflammatory signalingFrank Pajonk, Anja Riedisser, Michael Henke, et al.
Cancer Research|September 18, 2002
The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cellsFrank Pajonk, Judith Himmelsbach, Katrin Riess, et al.
Stem Cells (Dayton, Ohio)|April 11, 2012
Radiation-induced reprogramming of breast cancer cellsChann Lagadec, Erina Vlashi, Lorenza Della Donna, et al.
Neoplasia (New York, N.Y.)|December 18, 2007
Effects of recombinant erythropoietin on breast cancer-initiating cellsTiffany M Phillips, Kwanghee Kim, Erina Vlashi, et al.
Pageof 7